Emily Marine Leproust
Co-Founder, Chief Executive Officer and Director
Bio Sciences
Twist Bioscience
United States of America
Biography
Dr. Emily Marine Leproust co-founded Twist Bioscience Corporation and serves as its Chief Executive Officer and Director. She architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases and she developed Agilent’s Oligo Library Synthesis technology. Dr. Leproust has co-authored over 34 peer-reviewed papers, many on synthetic DNA and has extensive marketing, management and business development experience. Prior to Twist Bioscience, she was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.
Research Interest
Pharmaceutical Sciences
